DICKKOPF HOMOLOG 3 AS TARGET/MARKER OF BETA CELL FAILURE
摘要
<p>The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of DKK-3 in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.</p>
申请公布号
WO2006010534(A1)
申请公布日期
2006.02.02
申请号
WO2005EP07858
申请日期
2005.07.19
申请人
F.HOFFMANN-LA ROCHE AG;CHRIST, ANDREAS;EVERS, STEFAN;KRAPFENBAUER, KURT;SEBOKOVA, ELENA
发明人
CHRIST, ANDREAS;EVERS, STEFAN;KRAPFENBAUER, KURT;SEBOKOVA, ELENA
